ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Medicine & Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-32U2391
Home | Market Reports | Health| Pharmacy
COVID 19 Impact on Global Nuclear Medicine Radiopharmaceuticals Market Insights Forecast to 2026
BUY CHAPTERS

Global Nuclear Medicine & Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-32U2391
Report
June 2025
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
China Isotope & Radiation
Dongcheng
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
Siemens AG
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma

Nuclear Medicine & Radiopharmaceuticals Market Size

In 2024, the global market size of Nuclear Medicine & Radiopharmaceuticals was estimated to be worth US$ 6678 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.

Nuclear Medicine & Radiopharmaceuticals Market

Nuclear Medicine & Radiopharmaceuticals Market

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals.
The Nuclear Medicine & Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine & Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine & Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Nuclear Medicine & Radiopharmaceuticals Market Report

Report Metric Details
Report Name Nuclear Medicine & Radiopharmaceuticals Market
CAGR 7.3%
Segment by Type
Segment by Application
  • Oncology
  • Thyroid
  • Cardiology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Nuclear Medicine & Radiopharmaceuticals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine & Radiopharmaceuticals sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

Who are the main players in the Nuclear Medicine & Radiopharmaceuticals Market report?

Ans: The main players in the Nuclear Medicine & Radiopharmaceuticals Market are Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng

What are the Application segmentation covered in the Nuclear Medicine & Radiopharmaceuticals Market report?

Ans: The Applications covered in the Nuclear Medicine & Radiopharmaceuticals Market report are Oncology, Thyroid, Cardiology, Others

What are the Type segmentation covered in the Nuclear Medicine & Radiopharmaceuticals Market report?

Ans: The Types covered in the Nuclear Medicine & Radiopharmaceuticals Market report are Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

Recommended Reports

Radiopharmaceuticals Market

Radioisotopes & Therapy

Diagnostic Imaging Agents

1 Study Coverage
1.1 Nuclear Medicine & Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapeutic Radiopharmaceuticals
1.3 Market by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2020-2031
2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2020-2031
2.2 Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2024 Versus 2031
2.3 Nuclear Medicine & Radiopharmaceuticals Sales by Region (2020-2031)
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2020-2025
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2026-2031)
2.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2020-2031)
2.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2020-2025
2.4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2026-2031)
2.4.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2031)
3.1.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Volume by Type (2020-2031)
3.1.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2020-2031)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2020-2031)
3.1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2020-2031)
3.1.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2020-2031)
3.1.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2031)
3.2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Volume by Application (2020-2031)
3.2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2020-2031)
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2020-2031)
3.2.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2020-2031)
3.2.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2020-2031)
3.2.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Diagnostic Radiopharmaceuticals of Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application
3.3.2 Therapeutic Radiopharmaceuticals of Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application
4 Global Nuclear Medicine & Radiopharmaceuticals by Manufacturers
4.1 Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Sales (2020-2025)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer (2020-2025)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue (2020-2025)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2020-2025)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturer (2020-2025)
4.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Nuclear Medicine & Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
4.4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Base Distribution, Product Type
4.5.1 Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
4.5.3 Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type and Application
4.5.4 Diagnostic Radiopharmaceuticals Market Sales of Nuclear Medicine & Radiopharmaceuticals by Manufacturer
4.5.5 Therapeutic Radiopharmaceuticals Market Sales of Nuclear Medicine & Radiopharmaceuticals by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Cardinal Health
5.1.1 Cardinal Health Company Information
5.1.2 Cardinal Health Description, Business Overview
5.1.3 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Products Offered
5.1.4 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.1.6 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.1.7 Cardinal Health Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.1.8 Cardinal Health Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Company Information
5.2.2 GE Healthcare Description, Business Overview
5.2.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Products Offered
5.2.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.2.6 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.2.7 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.2.8 GE Healthcare Recent Developments
5.3 Jubilant Pharma
5.3.1 Jubilant Pharma Company Information
5.3.2 Jubilant Pharma Description, Business Overview
5.3.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Products Offered
5.3.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.3.6 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.3.7 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.3.8 Jubilant Pharma Recent Developments
5.4 Novartis
5.4.1 Novartis Company Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Nuclear Medicine & Radiopharmaceuticals Products Offered
5.4.4 Novartis Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.4.6 Novartis Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.4.7 Novartis Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Curium Pharma
5.5.1 Curium Pharma Company Information
5.5.2 Curium Pharma Description, Business Overview
5.5.3 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Products Offered
5.5.4 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.5.6 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.5.7 Curium Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.5.8 Curium Pharma Recent Developments
5.6 SIEMENS
5.6.1 SIEMENS Company Information
5.6.2 SIEMENS Description, Business Overview
5.6.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Products Offered
5.6.4 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.6.5 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.6.6 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.6.7 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.6.8 SIEMENS Recent Developments
5.7 Lantheus
5.7.1 Lantheus Company Information
5.7.2 Lantheus Description, Business Overview
5.7.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Products Offered
5.7.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.7.6 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.7.7 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.7.8 Lantheus Recent Developments
5.8 Bracco Imaging
5.8.1 Bracco Imaging Company Information
5.8.2 Bracco Imaging Description, Business Overview
5.8.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Products Offered
5.8.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.8.6 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.8.7 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.8.8 Bracco Imaging Recent Developments
5.9 Bayer
5.9.1 Bayer Company Information
5.9.2 Bayer Description, Business Overview
5.9.3 Bayer Nuclear Medicine & Radiopharmaceuticals Products Offered
5.9.4 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Bayer Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.9.6 Bayer Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.9.7 Bayer Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.9.8 Bayer Recent Developments
5.10 Eli Lilly
5.10.1 Eli Lilly Company Information
5.10.2 Eli Lilly Description, Business Overview
5.10.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Products Offered
5.10.4 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.10.6 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.10.7 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.10.8 Eli Lilly Recent Developments
5.11 Aurobindo Pharma
5.11.1 Aurobindo Pharma Company Information
5.11.2 Aurobindo Pharma Description, Business Overview
5.11.3 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Products Offered
5.11.4 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.11.6 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.11.7 Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.11.8 Aurobindo Pharma Recent Developments
5.12 Mundipharma
5.12.1 Mundipharma Company Information
5.12.2 Mundipharma Description, Business Overview
5.12.3 Mundipharma Nuclear Medicine & Radiopharmaceuticals Products Offered
5.12.4 Mundipharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Mundipharma Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.12.6 Mundipharma Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.12.7 Mundipharma Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.12.8 Mundipharma Recent Developments
5.13 China Isotope & Radiation
5.13.1 China Isotope & Radiation Company Information
5.13.2 China Isotope & Radiation Description, Business Overview
5.13.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
5.13.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.13.5 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.13.6 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.13.7 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.13.8 China Isotope & Radiation Recent Developments
5.14 Dongcheng
5.14.1 Dongcheng Company Information
5.14.2 Dongcheng Description, Business Overview
5.14.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Products Offered
5.14.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales by Product in 2024
5.14.6 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales by Application in 2024
5.14.7 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Area in 2024
5.14.8 Dongcheng Recent Developments
6 North America
6.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2020-2031
6.2 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
6.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2031)
6.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2031)
6.3 North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025)
6.4 North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Region
7.2.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2020-2031)
7.2.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2020-2031)
7.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025)
7.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025)
8 Europe
8.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2020-2031
8.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
8.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2031)
8.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2031)
8.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025)
8.4 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2020-2031
9.2 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2031)
9.2.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2031)
9.3 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025)
9.4 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2031)
10.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2031)
10.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025)
10.4 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Nuclear Medicine & Radiopharmaceuticals Supply Chain Analysis
11.2 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
11.3 Nuclear Medicine & Radiopharmaceuticals Clients Analysis
11.4 Nuclear Medicine & Radiopharmaceuticals Sales Channel and Sales Model Analysis
11.4.1 Nuclear Medicine & Radiopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Nuclear Medicine & Radiopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Nuclear Medicine & Radiopharmaceuticals Distributors
12 Nuclear Medicine & Radiopharmaceuticals Market Dynamics
12.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
12.2 Nuclear Medicine & Radiopharmaceuticals Market Drivers
12.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges
12.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
China Isotope & Radiation
Dongcheng
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
Siemens AG
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
List of Tables
 Table 1. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
 Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2026-2031) & (K Dose)
 Table 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Nuclear Medicine & Radiopharmaceuticals Sales Volume by Type (2020-2025) & (K Dose)
 Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sales Volume by Type (2026-2031) & (K Dose)
 Table 10. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Nuclear Medicine & Radiopharmaceuticals Sales Volume by Application (2020-2025) & (K Dose)
 Table 13. Global Nuclear Medicine & Radiopharmaceuticals Sales Volume by Application (2026-2031) & (K Dose)
 Table 14. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer (2020-2025) & (K Dose)
 Table 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturer (2020-2025)
 Table 18. Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2020-2025) & (US$/Dose)
 Table 21. Ranking of Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2024)
 Table 24. Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
 Table 26. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Cardinal Health Company Information
 Table 29. Cardinal Health Description and Business Overview
 Table 30. Cardinal Health Nuclear Medicine & Radiopharmaceuticals Product
 Table 31. Cardinal Health Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 32. Cardinal Health Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 33. Cardinal Health Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 34. Cardinal Health Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 35. Cardinal Health Recent Developments
 Table 36. GE Healthcare Company Information
 Table 37. GE Healthcare Description and Business Overview
 Table 38. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product
 Table 39. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 40. GE Healthcare Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 41. GE Healthcare Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 42. GE Healthcare Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 43. GE Healthcare Recent Developments
 Table 44. Jubilant Pharma Company Information
 Table 45. Jubilant Pharma Description and Business Overview
 Table 46. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product
 Table 47. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 48. Jubilant Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 49. Jubilant Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 50. Jubilant Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 51. Jubilant Pharma Recent Developments
 Table 52. Novartis Company Information
 Table 53. Novartis Description and Business Overview
 Table 54. Novartis Nuclear Medicine & Radiopharmaceuticals Product
 Table 55. Novartis Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 56. Novartis Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 57. Novartis Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 58. Novartis Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 59. Novartis Recent Developments
 Table 60. Curium Pharma Company Information
 Table 61. Curium Pharma Description and Business Overview
 Table 62. Curium Pharma Nuclear Medicine & Radiopharmaceuticals Product
 Table 63. Curium Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 64. Curium Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 65. Curium Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 66. Curium Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 67. Curium Pharma Recent Developments
 Table 68. SIEMENS Company Information
 Table 69. SIEMENS Description and Business Overview
 Table 70. SIEMENS Nuclear Medicine & Radiopharmaceuticals Product
 Table 71. SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. SIEMENS Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 73. SIEMENS Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 74. SIEMENS Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 75. SIEMENS Recent Developments
 Table 76. Lantheus Company Information
 Table 77. Lantheus Description and Business Overview
 Table 78. Lantheus Nuclear Medicine & Radiopharmaceuticals Product
 Table 79. Lantheus Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 80. Lantheus Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 81. Lantheus Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 82. Lantheus Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 83. Lantheus Recent Developments
 Table 84. Bracco Imaging Company Information
 Table 85. Bracco Imaging Description and Business Overview
 Table 86. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product
 Table 87. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Bracco Imaging Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 89. Bracco Imaging Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 90. Bracco Imaging Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 91. Bracco Imaging Recent Developments
 Table 92. Bayer Company Information
 Table 93. Bayer Description and Business Overview
 Table 94. Bayer Nuclear Medicine & Radiopharmaceuticals Product
 Table 95. Bayer Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 96. Bayer Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 97. Bayer Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 98. Bayer Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 99. Bayer Recent Developments
 Table 100. Eli Lilly Company Information
 Table 101. Eli Lilly Description and Business Overview
 Table 102. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product
 Table 103. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Eli Lilly Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 105. Eli Lilly Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 106. Eli Lilly Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 107. Eli Lilly Recent Developments
 Table 108. Aurobindo Pharma Company Information
 Table 109. Aurobindo Pharma Description and Business Overview
 Table 110. Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Product
 Table 111. Aurobindo Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 112. Aurobindo Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 113. Aurobindo Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 114. Aurobindo Pharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 115. Aurobindo Pharma Recent Developments
 Table 116. Mundipharma Company Information
 Table 117. Mundipharma Description and Business Overview
 Table 118. Mundipharma Nuclear Medicine & Radiopharmaceuticals Product
 Table 119. Mundipharma Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 120. Mundipharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 121. Mundipharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 122. Mundipharma Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 123. Mundipharma Recent Developments
 Table 124. China Isotope & Radiation Company Information
 Table 125. China Isotope & Radiation Description and Business Overview
 Table 126. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product
 Table 127. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. China Isotope & Radiation Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 129. China Isotope & Radiation Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 130. China Isotope & Radiation Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 131. China Isotope & Radiation Recent Developments
 Table 132. Dongcheng Company Information
 Table 133. Dongcheng Description and Business Overview
 Table 134. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product
 Table 135. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 136. Dongcheng Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Product in 2024
 Table 137. Dongcheng Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Application in 2024
 Table 138. Dongcheng Sales Proportion of Nuclear Medicine & Radiopharmaceuticals by Geographic Area in 2024
 Table 139. Dongcheng Recent Developments
 Table 140. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 141. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 142. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 143. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 144. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
 Table 145. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
 Table 146. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
 Table 147. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2026-2031) & (K Dose)
 Table 148. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 149. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 150. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
 Table 151. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
 Table 152. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 153. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 154. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 155. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 156. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
 Table 157. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
 Table 158. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 159. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 160. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 161. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 162. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
 Table 163. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
 Table 164. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 165. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 166. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 167. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 168. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
 Table 169. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
 Table 170. Nuclear Medicine & Radiopharmaceuticals Key Raw Materials, Industry Status and Trend
 Table 171. Nuclear Medicine & Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
 Table 172. Nuclear Medicine & Radiopharmaceuticals Clients Status and Trend
 Table 173. Nuclear Medicine & Radiopharmaceuticals Typical Clients
 Table 174. Nuclear Medicine & Radiopharmaceuticals Distributors
 Table 175. Nuclear Medicine & Radiopharmaceuticals Market Trends
 Table 176. Nuclear Medicine & Radiopharmaceuticals Market Drivers
 Table 177. Nuclear Medicine & Radiopharmaceuticals Market Challenges
 Table 178. Nuclear Medicine & Radiopharmaceuticals Market Restraints
 Table 179. Research Programs/Design for This Report
 Table 180. Key Data Information from Secondary Sources
 Table 181. Key Data Information from Primary Sources
 Table 182. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Nuclear Medicine & Radiopharmaceuticals Product Picture
 Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2024 & 2031
 Figure 4. Diagnostic Radiopharmaceuticals Product Picture
 Figure 5. Therapeutic Radiopharmaceuticals Product Picture
 Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2024 & 2031
 Figure 8. Oncology
 Figure 9. Thyroid
 Figure 10. Cardiology
 Figure 11. Others
 Figure 12. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
 Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market Size 2020-2031 (US$ Million)
 Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Sales 2020-2031 (K Dose)
 Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
 Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2020-2025) & (US$/Dose)
 Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Application (2020-2025) & (US$/Dose)
 Figure 24. Diagnostic Radiopharmaceuticals of Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Therapeutic Radiopharmaceuticals of Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturer in 2024
 Figure 27. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Diagnostic Radiopharmaceuticals Market Sales Proportion by Manufacturer in 2024
 Figure 29. Therapeutic Radiopharmaceuticals Market Sales Proportion by Manufacturer in 2024
 Figure 30. North America Nuclear Medicine & Radiopharmaceuticals Revenue 2020-2031 (US$ Million)
 Figure 31. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2020-2025)
 Figure 32. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
 Figure 36. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2020-2025)
 Figure 37. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2020-2025)
 Figure 38. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 40. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 41. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2020-2025)
 Figure 42. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2020-2025)
 Figure 43. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
 Figure 46. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2020-2025)
 Figure 47. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2020-2025)
 Figure 48. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2020-2025)
 Figure 52. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2020-2025)
 Figure 53. Nuclear Medicine & Radiopharmaceuticals Supply Chain (Upstream and Downstream Market)
 Figure 54. Global Production Market Share of Nuclear Medicine & Radiopharmaceuticals Raw Materials by Region in 2024
 Figure 55. Nuclear Medicine & Radiopharmaceuticals Distribution Channels
 Figure 56. Global Nuclear Medicine & Radiopharmaceuticals Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 57. Global Nuclear Medicine & Radiopharmaceuticals Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Radiopharmaceutical Market Research Report 2025
Global SPECT and PET Radiopharmaceuticals Market Research Report 2024
Global Nuclear Medicine Market Research Report 2025
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Radiopharmaceutical Therapy Market Research Report 2025
Global Diagnostic Radiopharmaceuticals Market Research Report 2024
Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030
Global Radiopharmaceuticals for Diagnosis Market Research Report 2024
Global Diagnostic Radioisotopes Market Insights Forecast to 2030
Global SPECT Radiopharmaceuticals Market Research Report 2025
Global Targeted Radiopharmaceuticals Market Research Report 2024
Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radioactive Therapeutic Drugs Market Research Report 2024
Global Radiopharmaceutical Injector Market Research Report 2025
Global PET Radioisotope Radiopharmaceuticals in PET Imaging Market Research Report 2024
Global Radioisotopes in Medicine Market Research Report 2025
Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030
Global Medical Radioisotopes Market Research Report 2025
Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Jet Lag Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0R20253
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions